CRL vs UPXI · rev $2.00B vs P/E 1.8, rev $15.8M
Charles River Laboratories (CRL) versus Upexi Inc. (UPXI) — a side-by-side from cached financials, not a winner call.
Charles River Laboratories (CRL) is a diagnostics & research company listed on US.
Upexi Inc. (UPXI) is a internet content & information company listed on NASDAQ.
Latest reported CRL revenue for 2026-06-27 was $2.00B. Net income was -$16.3M. CRL currently screens at market cap $7.78B.
Latest reported UPXI revenue for 2025-06-30 was $15.8M. Net income was -$13.7M. UPXI currently screens at market cap $65.3M and trailing P/E 1.8.
CRL currently screens at market cap $7.78B. UPXI currently screens at market cap $65.3M and trailing P/E 1.8.
Not investment advice. Open the CRL and UPXI stock pages for the full models.
Not investment advice.